![Hostile Regulatory Environment Further Chills Diagnostics Market](https://www.g2intelligence.com/wp-content/uploads/2023/05/May23.LIR_.MandA-iStock-1206615949-1100x800-1-1080x675.jpg)
Hostile Regulatory Environment Further Chills Diagnostics Market
The biggest story in M&A dealmaking continues to be the deal that’s being undone—Illumina’s acquisition of GRAIL.
The biggest story in M&A dealmaking continues to be the deal that’s being undone—Illumina’s acquisition of GRAIL.
April was among the busiest months, in recent memory, in terms of both deal volume and significance in the diagnostics industry.
Product integration collaborations have become increasingly common, with five such deals being announced between February and mid-March.
Genomics software developer Allelica to collaborate with Taiwanese precision medicine firm to develop a multi-ancestry breast cancer test.
Specially crafted lab tests speed up adoption of novel drug treatments.